On November 28, 2022, Strand Therapeutics Inc. closed the transaction. The round of funding led by Five Paces Ventures, LP. The transaction included participation from Eli Lilly and Company, Potentum Partners, and existing investors Playground Global.

The company has received $97,000,000 in its series A round of funding.